Form 4: Agilon Health's Chief Technology Officer Reports Stock Transactions

Girish Venkatachaliah, Chief Technology Officer of Agilon Health, reports the vesting and settlement of performance-based restricted stock units (PSUs) and shares withheld for tax obligations.

Summary

• On March 14, 2024, Girish Venkatachaliah, the Chief Technology Officer of Agilon Health, had 5,434 performance-based restricted stock units (PSUs) vest, which were then settled for shares of common stock.
• The vesting of these PSUs was based on Agilon Health's revenue and adjusted EBITDA performance from January 1, 2021, through December 31, 2023, achieving 100% of the predetermined goals.
• Additionally, 1,883 shares of common stock were withheld by Agilon Health to cover income tax obligations related to the PSU settlement at a price of $5.23 per share.
• Following these transactions, Venkatachaliah directly owns 39,950 shares of common stock, which includes restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document simply reports stock transactions by an executive, which is a routine occurrence. The vesting of PSUs suggests the company met its performance goals, which is mildly positive.

Positives

• The vesting of PSUs indicates that Agilon Health met its predetermined revenue and adjusted EBITDA goals over the three-year performance period.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like the CTO in this case, engage in transactions involving the company's stock. It provides transparency to the market regarding insider activity.

Stakeholder Impact

• Shareholders are informed about insider transactions, providing transparency into executive compensation and stock ownership.

Key Dates